Further evidence that the expression of CD38 and HLA-DR+ in CD8+ lymphocytes does not correlate to disease progression in HIV-1 vertically infected children

Journal of the International Association of Physicians in AIDS Care

Volumn 11, Issue 3, 2012, Pages 164-168

  Romeiro, Juliana Ribeiro ^a   Pinto, Jorge Andrade ^a   Silva, Maria Luiza ^a   Eloi Santos, Silvana Maria ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

CD38; HIV; HLA DR; slow progressing children; Treg

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; ANTIGENS, CD38; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LYMPHOCYTE ACTIVATION; MALE; PROGNOSIS; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 84860713175     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109711421642     Document Type: Review

References (21)

1. Ofori-Mante JA, Kaul A, Rigaud M, et al. Natural history of HIV infected pediatric long-term or slow progressor population after the first decade of life. Pediatr Infect Dis J. 2007 ; 26 (3). 217-220
2. Resino S, Bellón JM, Pérez A, Gurbindo Gutiérrez MD, Muñoz-Fernández MA. Subsets of CD8+ T cells in longterm asymptomatic vertically HIV-1 infected children [in Spanish]. Med Clin (Barc). 2004 ; 122 (1). 6-11
3. Resino S, Bellón JM, Gurbindo MD, Muñoz-Fernández MA. CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy. Clin Infect Dis. 2004 ; 38 (3). 412-417
4. Ssewanyana I, Baker CA, Ruel T, et al. The distribution and immune profile of T Cell subsets in HIV-infected children from Uganda. AIDS Res Hum Retroviruses. 2009 ; 25 (1). 65-71
5. de Martino M, Rossi ME, Azzari C, Gelli MG, Galli L, Vierucci A. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years. Pediatr Res. 1998 ; 43 (6). 752-758
6. Plaeger-Marshall S, Isacescu V, O'Rourke S, Bertolli J, Bryson YJ, Stiehm ER. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol. 1994 ; 71 (1). 19-26
7. Rosenblatt HM, Stanley KE, Song LY, et al. Pediatric AIDS clinical trials group 377 study team Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. J Infect Dis. 2005 ; 192 (3). 445-455
8. Terzieva V. Regulatory T cells and HIV-1 infection. Viral Immunol. 2008 ; 21 (3). 285-291
9. Eggena MP, Barugahare B, Jones N, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol. 2005 ; 174 (7). 4407-4414
10. Apoil PA, Puissant B, Roubinet F, Abbal M, Massip P, Blancher A. FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr. 2005 ; 39 (4). 381-385
11. Zaunders JJ, Ip S, Munier ML, et al. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol. 2006 ; 80 (20). 10162-10172
12. Montes M, Lewis DE, Sanchez C. Foxp3 regulatory T cells in antiretroviral-naive HIV patients. AIDS. 2006 ; 20 (12). 1669-1671
13. Epple HJ, Loddenkemper C, Kunkel D, et al. Mucosal but not peripheral FOXP3 regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.. Blood. 2006 ; 108 (9). 3072-3078.
14. Biancotto A, Iglehart SJ, Vanpouille C, et al. HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood. 2008 ; 111 (2). 699-704
15. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998 ; 396 (6712). 690-695
16. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 2004 ; 104 (4). 942-947
17. Paul ME, Shearer WT, Kozinetz CA, Lewis DE. Comparison of CD8+ T-cell subsets in HIV-infected rapid progressor children versus non-rapid progressor children. J Allergy Clin Immunol. 2001 ; 108 (2). 258-264
18. Sauce D, Larsen M, Fastenackels S, et al. HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood. 2011 ; 117 (19). 5142-5151
19. Alexander L, Cuchura L, Simpson BJ, Andiman WA. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors. Pediatr Infect Dis J. 2006 ; 25 (2). 135-141
20. Cao W, Jamieson BD, Hultin LE, Hultin PM, Detels R. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses. 2009 ; 25 (2). 183-191
21. Freguja R, Gianesin K, Mosconi I, et al. Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children. Clin Exp Immunol. 2011 ; 164 (3). 373-380